MISOPROSTOL - DISCOVERY, DEVELOPMENT, AND CLINICAL-APPLICATIONS

[1] CYTOPROTECTION BY A SYNTHETIC PROSTAGLANDIN AGAINST ETHANOL-INDUCED GASTRIC-MUCOSAL DAMAGE - A DOUBLE-BLIND ENDOSCOPIC STUDY IN HUMAN-SUBJECTS [J]. GASTROINTESTINAL ENDOSCOPY, 1986, 32 (02) : 67 - 70

[2] HEALING OF BENIGN GASTRIC-ULCER - A PLACEBO-CONTROLLED COMPARISON OF 2 DOSAGE REGIMENS OF MISOPROSTOL, A SYNTHETIC ANALOG OF PROSTAGLANDIN-E1 [J]. DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) : S164 - S170

[3] AKDAMAR K, 1982, AM J GASTROENTEROL, V77, P902

[4] NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND LIFE THREATENING COMPLICATIONS OF PEPTIC-ULCERATION [J]. GUT, 1987, 28 (05) : 527 - 532

[5] BAUER RF, 1987, FED PROC, V46, P1085

[6] MISOPROSTOL PRECLINICAL PHARMACOLOGY [J]. DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) : S118 - S125

[7] CARDIOVASCULAR AND METABOLIC RESPONSE TO INFUSIONS OF PROSTAGLANDIN E AND TO SIMULTANEOUS INFUSIONS OF NORADRENALINE AND PROSTAGLANDIN E IN MAN - PROSTAGLANDIN AND RELATED FACTORS 35 [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1965, 64 (04): : 332 - +

[8] Bindra J. S., 1977, PROSTAGLANDIN SYNTHE

[9] PROSTAGLANDINS AND CONGENERS .29. (16RS)-(+/-)-15-DEOXY-16-HYDROXY-16-VINYL-PROSTAGLANDIN E2, AN ORALLY AND TRANSDERMALLY ACTIVE HYPOTENSIVE AGENT OF PROLONGED DURATION [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (05) : 492 - 494

[10] DOUBLE-BLIND COMPARISON OF 2 DOSAGE REGIMENS OF MISOPROSTOL IN THE TREATMENT OF DUODENAL ULCERATION [J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (10) : 1269 - 1273

[1] CYTOPROTECTION BY A SYNTHETIC PROSTAGLANDIN AGAINST ETHANOL-INDUCED GASTRIC-MUCOSAL DAMAGE - A DOUBLE-BLIND ENDOSCOPIC STUDY IN HUMAN-SUBJECTS [J]. GASTROINTESTINAL ENDOSCOPY, 1986, 32 (02) : 67 - 70

[2] HEALING OF BENIGN GASTRIC-ULCER - A PLACEBO-CONTROLLED COMPARISON OF 2 DOSAGE REGIMENS OF MISOPROSTOL, A SYNTHETIC ANALOG OF PROSTAGLANDIN-E1 [J]. DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) : S164 - S170

[3] AKDAMAR K, 1982, AM J GASTROENTEROL, V77, P902

[4] NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND LIFE THREATENING COMPLICATIONS OF PEPTIC-ULCERATION [J]. GUT, 1987, 28 (05) : 527 - 532

[5] BAUER RF, 1987, FED PROC, V46, P1085

[6] MISOPROSTOL PRECLINICAL PHARMACOLOGY [J]. DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) : S118 - S125

[7] CARDIOVASCULAR AND METABOLIC RESPONSE TO INFUSIONS OF PROSTAGLANDIN E AND TO SIMULTANEOUS INFUSIONS OF NORADRENALINE AND PROSTAGLANDIN E IN MAN - PROSTAGLANDIN AND RELATED FACTORS 35 [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1965, 64 (04): : 332 - +

[8] Bindra J. S., 1977, PROSTAGLANDIN SYNTHE

[9] PROSTAGLANDINS AND CONGENERS .29. (16RS)-(+/-)-15-DEOXY-16-HYDROXY-16-VINYL-PROSTAGLANDIN E2, AN ORALLY AND TRANSDERMALLY ACTIVE HYPOTENSIVE AGENT OF PROLONGED DURATION [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (05) : 492 - 494

[10] DOUBLE-BLIND COMPARISON OF 2 DOSAGE REGIMENS OF MISOPROSTOL IN THE TREATMENT OF DUODENAL ULCERATION [J]. DIGESTIVE DISEASES AND SCIENCES, 1988, 33 (10) : 1269 - 1273